Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

675
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
675
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

598
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
598
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Violation detection in power operation sites based on multi-scale detection and few-shot learning.

Frontiers in artificial intelligence·2026
Same author

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Association between Impaired Lung Function and Pulmonary Perfusion Defects Assessed by Phase-resolved Functional Lung MRI.

Radiology. Cardiothoracic imaging·2026
Same author

Beyond the Base Case: Payment Perspective and Ductal Carcinoma In Situ Management Assumptions in Artificial-Intelligence-Assisted Breast Screening Models.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Potential factors influencing quality of life in Chinese adult women with urinary incontinence: a nationwide cross-sectional study.

World journal of urology·2026
Same author

Machine learning and SHAP interpretation for predicting coronary heart disease-diabetes comorbidity with dietary antioxidants.

Scientific reports·2026
Same journal

Prognostic Impact of Chronotropic Incompetence in Transthyretin Cardiac Amyloidosis. A multicentre study.

ESC heart failure·2026
Same journal

Composite Primary Endpoint: A Stratagem of Endpoint Selection for Heart Failure Randomized Clinical Trial.

ESC heart failure·2026
Same journal

Prediction of Incident Heart Failure in Men and Women with a History of Myocardial Infarction.

ESC heart failure·2026
Same journal

Achalasia-induced reversible sinus node dysfunction in DSP/TNNI3 cardiomyopathy: an extracardiac cause of sinus pauses mimicking progression of genetic cardiomyopathy.

ESC heart failure·2026
Same journal

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure: Exploratory Analysis of the PRELIEVE study.

ESC heart failure·2026
Same journal

Frailty and Heart Failure: An Integrated Review of a Bidirectional Relationship.

ESC heart failure·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.5K

Enhancing myocardial function with cardiac contractility modulation: potential and challenges.

Zihan Li1,2, Qiming Liu1, Shenghua Zhou1

  • 1Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.

ESC Heart Failure
|November 10, 2023
PubMed
Summary
This summary is machine-generated.

Cardiac contractility modulation (CCM) is a new heart failure therapy for select patients. Further research is needed to confirm benefits and expand its use in diverse patient groups.

Keywords:
Cardiac contractility modulationCardiac devicesDevice implantationHeart failure

More Related Videos

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes
09:17

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes

Published on: August 9, 2022

2.1K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

7.6K

Related Experiment Videos

Last Updated: Jul 11, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.5K
Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes
09:17

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes

Published on: August 9, 2022

2.1K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

7.6K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Heart Failure Management

Background:

  • Cardiac contractility modulation (CCM) presents a novel therapeutic option for heart failure (HF) patients.
  • CCM is particularly relevant for individuals unresponsive to cardiac resynchronization therapy (CRT) within specific QRS duration criteria.
  • Existing research primarily focuses on left ventricular effects, leaving gaps in understanding CCM's impact on other patient subsets.

Purpose of the Study:

  • To review the mechanistic basis of CCM.
  • To evaluate CCM's effects on myocardial function and its applicability across various patient demographics.
  • To identify limitations and areas for future research in CCM therapy.

Main Methods:

  • Literature review of existing studies on Cardiac Contractility Modulation.
  • Analysis of CCM's impact on myocardial function and patient outcomes.
  • Identification of knowledge gaps and future research directions.

Main Results:

  • CCM demonstrates potential as a therapeutic strategy for specific heart failure populations.
  • Insufficient data currently exists regarding CCM's impact on mortality and hospitalization rates.
  • Specialized skills are required for CCM device implantation, and research on left ventricular effects dominates.

Conclusions:

  • CCM offers a promising avenue for heart failure treatment, but requires further investigation.
  • Future studies should focus on mortality/hospitalization benefits, combinatory therapies, and atrial fibrillation's impact on implantation.
  • Expanding research scope can refine CCM outcomes and broaden its patient applicability.